A cascade of cytokines mediates mechanical inflammatory hypernociception in mice
Top Cited Papers
Open Access
- 21 January 2005
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (5) , 1755-1760
- https://doi.org/10.1073/pnas.0409225102
Abstract
The hypernociceptive effects of cytokines [TNF-α, keratinocyte-derived chemokine (KC), and IL-1β] and their participation in carrageenan (Cg)-induced inflammatory hypernociception in mice were investigated. Nociceptor sensitization (hypernociception) was quantified with an electronic version of the von Frey filament test in WT and TNF receptor type 1 knockout mice (TNF-R1–/–). TNF-α-induced hypernociception was abolished in TNF-R1–/– mice, partially inhibited by pretreatment with IL-1 receptor antagonist (IL-1ra) or indomethacin and unaffected by Ab against KC (AbKC) or guanethidine. IL-1ra and indomethacin pretreatment strongly inhibited the hypernociception induced by IL-1β, which was not altered by AbKC or guanethidine or by knocking out TNF-R1. KC-induced hypernociception was abolished by AbKC, inhibited by pretreatment with indomethacin plus guanethidine, and partially inhibited by IL-1ra, indomethacin, or guanethidine. In contrast, KC-induced hypernociception was not altered by knocking out TNF-R1. Cg-induced hypernociception was abolished by administration of indomethacin plus guanethidine, diminished in TNF-R1–/– mice, and partially inhibited in WT mice pretreated with AbKC, IL-1ra, indomethacin, or guanethidine. TNF-α, KC, and IL-1β concentrations were elevated in the skin of Cg-injected paws. The TNF-α and KC concentrations rose concomitantly and peaked before that of IL-1β. In mice, the cytokine cascade begins with the release of TNF-α (acting on TNF-R1 receptor) and KC, which stimulate the release of IL-1β. As in rats, the final mediators of this cascade were prostaglandins released by IL-1β and sympathetic amines released by KC. These results extend to mice the concept that the release of primary mediators responsible for hypernociception is preceded by a cascade of cytokines.Keywords
This publication has 55 references indexed in Scilit:
- Bradykinin B1 and B2 receptors, tumour necrosis factor α and inflammatory hyperalgesiaBritish Journal of Pharmacology, 1999
- Role of lipocortin‐1 in the anti‐hyperalgesic actions of dexamethasoneBritish Journal of Pharmacology, 1997
- Effects of regional intravenous guanethidine in patients with neuralgia in the hand; a follow-up study over a decadePain, 1995
- THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITISRheumatology, 1995
- Electromotive administration of guanethidine for treatment of reflex sympathetic dystrophy: A pilot study in eight patientsJournal of Pain and Symptom Management, 1994
- Contribution of protein kinase C to central sensitization and persistent pain following tissue injuryNeuroscience Letters, 1992
- Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levelsInflammation Research, 1988
- Phosgene measurements in the upper troposphere and lower stratosphereNature, 1988
- A peripheral sympathetic component in inflammatory hyperalgesiaEuropean Journal of Pharmacology, 1987
- Penicillamine causing acute colitis.BMJ, 1979